A detailed history of Ars Investment Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ars Investment Partners, LLC holds 121,792 shares of MRK stock, worth $11.9 Million. This represents 1.42% of its overall portfolio holdings.

Number of Shares
121,792
Previous 122,430 0.52%
Holding current value
$11.9 Million
Previous $15.2 Million 8.75%
% of portfolio
1.42%
Previous 1.6%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$111.15 - $128.97 $70,913 - $82,282
-638 Reduced 0.52%
121,792 $13.8 Million
Q2 2024

Jul 17, 2024

SELL
$123.8 - $132.96 $32,435 - $34,835
-262 Reduced 0.21%
122,430 $15.2 Million
Q1 2024

May 02, 2024

SELL
$113.24 - $131.95 $18,684 - $21,771
-165 Reduced 0.13%
122,692 $16.2 Million
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $473,951 - $515,773
4,731 Added 4.01%
122,857 $13.4 Million
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $44,680 - $49,619
-434 Reduced 0.37%
118,126 $12.2 Million
Q2 2023

Jul 11, 2023

SELL
$108.61 - $118.38 $139,020 - $151,526
-1,280 Reduced 1.07%
118,560 $13.7 Million
Q1 2023

Apr 05, 2023

BUY
$102.94 - $114.86 $65,161 - $72,706
633 Added 0.53%
119,840 $12.7 Million
Q4 2022

Jan 25, 2023

SELL
$87.44 - $112.11 $1.22 Million - $1.57 Million
-13,989 Reduced 10.5%
119,207 $0
Q3 2022

Oct 07, 2022

BUY
$84.53 - $94.96 $1.17 Million - $1.31 Million
13,837 Added 11.59%
133,196 $11.5 Million
Q2 2022

Jul 15, 2022

SELL
$83.49 - $94.64 $50,010 - $56,689
-599 Reduced 0.5%
119,359 $10.9 Million
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $5,586 - $6,262
76 Added 0.06%
119,958 $9.84 Million
Q4 2021

Feb 11, 2022

BUY
$72.28 - $90.54 $224,212 - $280,855
3,102 Added 2.66%
119,882 $9.19 Million
Q3 2021

Nov 05, 2021

SELL
$71.68 - $78.83 $55,408 - $60,935
-773 Reduced 0.66%
116,780 $8.77 Million
Q2 2021

Aug 06, 2021

SELL
$70.31 - $77.77 $50,693 - $56,072
-721 Reduced 0.61%
117,553 $9.14 Million
Q1 2021

May 13, 2021

SELL
$68.86 - $81.11 $111,002 - $130,749
-1,612 Reduced 1.34%
118,274 $9.12 Million
Q4 2020

Feb 09, 2021

SELL
$71.77 - $79.65 $43,636 - $48,427
-608 Reduced 0.5%
119,886 $9.81 Million
Q3 2020

Nov 12, 2020

SELL
$73.18 - $82.95 $22,539 - $25,548
-308 Reduced 0.25%
120,494 $10 Million
Q2 2020

Aug 13, 2020

BUY
$70.42 - $80.13 $1.07 Million - $1.22 Million
15,192 Added 14.39%
120,802 $9.34 Million
Q1 2020

May 12, 2020

SELL
$63.36 - $87.82 $41,247 - $57,170
-651 Reduced 0.61%
105,610 $8.13 Million
Q4 2019

Feb 12, 2020

SELL
$77.58 - $87.54 $48,797 - $55,062
-629 Reduced 0.59%
106,261 $9.66 Million
Q3 2019

Nov 14, 2019

SELL
$76.08 - $82.93 $1.12 Million - $1.22 Million
-14,692 Reduced 12.08%
106,890 $9 Million
Q2 2019

Aug 12, 2019

BUY
$69.84 - $81.59 $920,491 - $1.08 Million
13,180 Added 12.16%
121,582 $10.2 Million
Q1 2019

May 09, 2019

SELL
$69.58 - $79.36 $153,702 - $175,306
-2,209 Reduced 2.0%
108,402 $9.02 Million
Q4 2018

Feb 13, 2019

BUY
$65.24 - $75.71 $7.22 Million - $8.37 Million
110,611 New
110,611 $8.45 Million
Q3 2018

Nov 13, 2018

SELL
$57.69 - $67.84 $1.65 Million - $1.94 Million
-28,570 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$50.83 - $59.72 $1.45 Million - $1.71 Million
28,570 New
28,570 $1.73 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Ars Investment Partners, LLC Portfolio

Follow Ars Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ars Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ars Investment Partners, LLC with notifications on news.